0001209191-19-024466.txt : 20190412
0001209191-19-024466.hdr.sgml : 20190412
20190412160050
ACCESSION NUMBER: 0001209191-19-024466
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190410
FILED AS OF DATE: 20190412
DATE AS OF CHANGE: 20190412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WAGNER CHARLES F JR
CENTRAL INDEX KEY: 0001223348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 19746286
MAIL ADDRESS:
STREET 1: C/O MILLIPORE CORP
CITY: BILLERICA
STATE: MA
ZIP: 01820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-10
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001223348
WAGNER CHARLES F JR
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP and CFO
Common Stock
2019-04-10
4
A
0
3697
0.00
A
3697
D
Stock Option (Right to Buy)
189.38
2019-04-10
4
A
0
9532
0.00
A
2029-04-09
Common Stock
9532
9532
D
Restricted stock unit award that vests in three annual installments on 4/30/20, 4/30/21, and 4/30/22.
The option vests in 16 quarterly installments from 4/10/2019.
/s/ Omar White, Attorney-in-Fact
2019-04-12